Skip to main content

2022 | OriginalPaper | Buchkapitel

PET-Neuroimaging and Neuropsychological Study for Early Cognitive Impairment in Parkinson’s Disease

verfasst von : Sergey Lytaev

Erschienen in: Bioinformatics and Biomedical Engineering

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

To present time, the world science has accumulated a sufficient amount of information on the quantitative changes in the rate of glucose utilization according to positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) in Parkinson’s disease (PD) with dementia. It was found that in the early stages of dementia with PD, there is a dysfunction of the frontal lobes, while PET examination of patients with PD with dementia shows the quantitative changes in the rate of glucose utilization. On this basis, it seems relevant to compare the functional state of the brain structures and the results of neuropsychological studies in patients with PD with varying severity of cognitive impairment. The present research was aimed to investigate the relationship between early cognitive violations according to neuropsychological research and the rate of glucose metabolism in different brain areas during PET scanning in patients with Parkinson’s disease. Neuropsychological testing consisted of clinical interviews, observation, questioning, Mini-Mental State Exam (MMSE) and frontal assessment battery (FAB). According to the research outcomes, it was found that with initial cognitive impairment, determined by FAB, a quantitative change in the rate of glucose utilization is observed, similar to the pattern found in patients with cognitive disorders in PD. Four factors were established: factor 1 – dorsal system of attention (voluntary attention), factor 2 – ventral system of attention (involuntary attention), factor 3 – system of the state of operational rest, factor 4 – visual projective zone. The precentral cortex of the frontal areas and the upper half of the parietal zones of big brain are constitute the 1st factor. The anterior third of the convexital part of the frontal areas and the lower half of the parietal zones are the 2nd factor. The 3rd factor includes the 23, 36, 29 and 30 cytoarchitectonic Brodmann fields (the posterior cingulate gyrus). Primary visual area (17th Brodmann’s field) is the 4th factor.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Aarsland, D., Zaccai, J., Brayne, C.: A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov. Disord. 20, 1255–1263 (2005)CrossRef Aarsland, D., Zaccai, J., Brayne, C.: A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov. Disord. 20, 1255–1263 (2005)CrossRef
3.
Zurück zum Zitat Buchert, R., Buhmann, C., Apostolova, I., Meyer, P.T., Gallinat, J.: Nuclear imaging in the diagnosis of clinically uncertain parkinsonian syndromes. Dtsch. Arztebl. Int. 116, 747–754 (2019)PubMedPubMedCentral Buchert, R., Buhmann, C., Apostolova, I., Meyer, P.T., Gallinat, J.: Nuclear imaging in the diagnosis of clinically uncertain parkinsonian syndromes. Dtsch. Arztebl. Int. 116, 747–754 (2019)PubMedPubMedCentral
4.
Zurück zum Zitat Campoy, A.-D.T., Liang, C., Ladwa, R.M., et al.: [18F] Nifene PET/CT imaging in mice: improved methods and preliminary studies of α4β2* nicotinic acetylcholinergic receptors in transgenic A53T mouse model of α-synucleinopathy and post-mortem human Parkinson’s disease. Molecules 26, 7360 (2021)CrossRef Campoy, A.-D.T., Liang, C., Ladwa, R.M., et al.: [18F] Nifene PET/CT imaging in mice: improved methods and preliminary studies of α4β2* nicotinic acetylcholinergic receptors in transgenic A53T mouse model of α-synucleinopathy and post-mortem human Parkinson’s disease. Molecules 26, 7360 (2021)CrossRef
5.
Zurück zum Zitat Cohen, O.S., Vakil, E., Tanne, D., et al.: The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease. J. Geriatr. Psychiatry Neurol. 2, 71–77 (2012)CrossRef Cohen, O.S., Vakil, E., Tanne, D., et al.: The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease. J. Geriatr. Psychiatry Neurol. 2, 71–77 (2012)CrossRef
6.
Zurück zum Zitat Ferri, C.P., Prince, M., Brayne, C., et al.: Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112–2117 (2005)CrossRef Ferri, C.P., Prince, M., Brayne, C., et al.: Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112–2117 (2005)CrossRef
7.
Zurück zum Zitat Folstein, M.F., Folstein, S.E., McHugh, P.R.: Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res. 2, 189–198 (1975)CrossRef Folstein, M.F., Folstein, S.E., McHugh, P.R.: Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res. 2, 189–198 (1975)CrossRef
8.
Zurück zum Zitat Fujimi, K., Sasaki, K., Noda, K., et al.: Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study. Brain Pathol. (Zurich, Switzerland). 18, 317–325 (2008)CrossRef Fujimi, K., Sasaki, K., Noda, K., et al.: Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study. Brain Pathol. (Zurich, Switzerland). 18, 317–325 (2008)CrossRef
9.
Zurück zum Zitat Gan, J., Liu, S., Wang, X., et al.: Clinical characteristics of Lewy body dementia in Chinese memory clinics. BMC Neurol. 21, 144 (2021)CrossRef Gan, J., Liu, S., Wang, X., et al.: Clinical characteristics of Lewy body dementia in Chinese memory clinics. BMC Neurol. 21, 144 (2021)CrossRef
10.
Zurück zum Zitat Hely, M.A., Morris, J.G., Reid, W.G.: Sydney multicenter study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov. Disord. 3, 190–199 (2005)CrossRef Hely, M.A., Morris, J.G., Reid, W.G.: Sydney multicenter study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov. Disord. 3, 190–199 (2005)CrossRef
12.
Zurück zum Zitat Khil’ko, V., Shostak, V., Khlunovskiǐ, A., et al.: The topographic mapping of evoked bioelectrical activity and other methods for the functional neural visualization of the brain. Vestn. Ross. Akad. Med. Nauk 3, 36–41 (1993) Khil’ko, V., Shostak, V., Khlunovskiǐ, A., et al.: The topographic mapping of evoked bioelectrical activity and other methods for the functional neural visualization of the brain. Vestn. Ross. Akad. Med. Nauk 3, 36–41 (1993)
13.
Zurück zum Zitat Leh, S.E., Petrides, M., Strafella, A.P.: The neural circuitry of executive functions in healthy subjects and Parkinson’s disease. Neuropsychopharmacology 1, 70–85 (2010)CrossRef Leh, S.E., Petrides, M., Strafella, A.P.: The neural circuitry of executive functions in healthy subjects and Parkinson’s disease. Neuropsychopharmacology 1, 70–85 (2010)CrossRef
14.
Zurück zum Zitat Loane, C., Politis, M.: Positron emission tomography neuroimaging in Parkinson’s disease. Am. J. Transl. Res. 3, 323–341 (2011)PubMedPubMedCentral Loane, C., Politis, M.: Positron emission tomography neuroimaging in Parkinson’s disease. Am. J. Transl. Res. 3, 323–341 (2011)PubMedPubMedCentral
15.
Zurück zum Zitat Lytaev, S.A., Susin, D.S.: PET-diagnostics of cognitive impairment in patients with Parkinson’s disease. Pediatrician 7, 63–68 (2016) Lytaev, S.A., Susin, D.S.: PET-diagnostics of cognitive impairment in patients with Parkinson’s disease. Pediatrician 7, 63–68 (2016)
16.
Zurück zum Zitat Lytaev, S., Aleksandrov, M., Popovich, T., Lytaev, M.: Auditory evoked potentials and PET-scan: early and late mechanisms of selective attention. Adv. Intell. Syst. Comput. 775, 169–178 (2019) Lytaev, S., Aleksandrov, M., Popovich, T., Lytaev, M.: Auditory evoked potentials and PET-scan: early and late mechanisms of selective attention. Adv. Intell. Syst. Comput. 775, 169–178 (2019)
18.
Zurück zum Zitat Lytaev, S.: Modeling and estimation of physiological, psychological and sensory indicators for working capacity. Adv. Intell. Syst. Comput. 1201, 207–213 (2021) Lytaev, S.: Modeling and estimation of physiological, psychological and sensory indicators for working capacity. Adv. Intell. Syst. Comput. 1201, 207–213 (2021)
19.
Zurück zum Zitat Lytaev, S.: Long-latency event-related potentials (300–1000 ms) of the visual insight. Sensors 22, 1323 (2022)CrossRef Lytaev, S.: Long-latency event-related potentials (300–1000 ms) of the visual insight. Sensors 22, 1323 (2022)CrossRef
20.
Zurück zum Zitat Murray, P.S., Kumar, S., Demichele-Sweet, M.A., Sweet, R.A.: Psychosis in Alzheimer’s disease. Biol. Psychiatry 75, 542–552 (2014)CrossRef Murray, P.S., Kumar, S., Demichele-Sweet, M.A., Sweet, R.A.: Psychosis in Alzheimer’s disease. Biol. Psychiatry 75, 542–552 (2014)CrossRef
21.
Zurück zum Zitat Palmqvist, S., Hansson, O., Minthon, L., Londos, E.: Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer’s disease with common cognitive tests. Int. J. Geriatr. Psychiatry 24, 1405–1412 (2009)CrossRef Palmqvist, S., Hansson, O., Minthon, L., Londos, E.: Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer’s disease with common cognitive tests. Int. J. Geriatr. Psychiatry 24, 1405–1412 (2009)CrossRef
22.
Zurück zum Zitat Poston, K.L., Eidelberg, D.: FDG PET in the evaluation of Parkinson’s disease. PET Clin. 1, 55–64 (2010)CrossRef Poston, K.L., Eidelberg, D.: FDG PET in the evaluation of Parkinson’s disease. PET Clin. 1, 55–64 (2010)CrossRef
23.
Zurück zum Zitat Silverman, D.H.S., Mosconi, L., Ercoli, L., et al.: PET scans obtained for evaluation of cognitive dysfunction. Semin. Nucl. Med. 38, 251–261 (2008)CrossRef Silverman, D.H.S., Mosconi, L., Ercoli, L., et al.: PET scans obtained for evaluation of cognitive dysfunction. Semin. Nucl. Med. 38, 251–261 (2008)CrossRef
24.
Zurück zum Zitat Surendranathan, A., Kane, J.P.M., Bentley, A., et al.: Clinical diagnosis of Lewy body dementia. BJPsych Open 6, e61 (2020)CrossRef Surendranathan, A., Kane, J.P.M., Bentley, A., et al.: Clinical diagnosis of Lewy body dementia. BJPsych Open 6, e61 (2020)CrossRef
25.
Zurück zum Zitat Szeto, J.Y.Y., Walton, C.C., Rizos, A., et al.: Dementia in long-term Parkinson’s disease patients: a multicentre retrospective study. NPJ Parkinson’s Dis. 6, 2 (2020)CrossRef Szeto, J.Y.Y., Walton, C.C., Rizos, A., et al.: Dementia in long-term Parkinson’s disease patients: a multicentre retrospective study. NPJ Parkinson’s Dis. 6, 2 (2020)CrossRef
26.
Zurück zum Zitat Talairach, J., Tournoux, P.: Co-planar stereotactic atlas of the human brain. In: 3-Dimensional Proportional System: An Approach to Cerebral Imaging, pp. 5–15. Thieme, New York (1988) Talairach, J., Tournoux, P.: Co-planar stereotactic atlas of the human brain. In: 3-Dimensional Proportional System: An Approach to Cerebral Imaging, pp. 5–15. Thieme, New York (1988)
27.
Zurück zum Zitat Taylor, J.P., McKeith, I.G., Burn, D.J., et al.: New evidence on the management of Lewy body dementia. Lancet Neurol. 19, 157–169 (2020)CrossRef Taylor, J.P., McKeith, I.G., Burn, D.J., et al.: New evidence on the management of Lewy body dementia. Lancet Neurol. 19, 157–169 (2020)CrossRef
28.
Zurück zum Zitat Thompson, E., Marrett, C., et al.: Performance evaluation of the PC-2048: a new 15-slice encoded-crystal PET scanner for neurological studies. IEEE Trans. Med. Imaging 2, 90–95 (1991) Thompson, E., Marrett, C., et al.: Performance evaluation of the PC-2048: a new 15-slice encoded-crystal PET scanner for neurological studies. IEEE Trans. Med. Imaging 2, 90–95 (1991)
Metadaten
Titel
PET-Neuroimaging and Neuropsychological Study for Early Cognitive Impairment in Parkinson’s Disease
verfasst von
Sergey Lytaev
Copyright-Jahr
2022
DOI
https://doi.org/10.1007/978-3-031-07704-3_12

Premium Partner